Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

NovaBay Pharmaceuticals

0.5875
+0.03746.80%
Volume:61.30K
Turnover:36.33K
Market Cap:3.42M
PE:-0.23
High:0.6235
Open:0.5500
Low:0.5500
Close:0.5501
Loading ...
OverviewCompanyNewsFilings
Apr 10, 2019

Correspondence

[Cover]Correspondence
Jan 13, 2017

Beneficial Ownership Change

新星湾制药有限公司
Jan 13, 2017

Beneficial Ownership Change

Aug 04, 2016

Beneficial Ownership Change

Jun 17, 2016

Correspondence

Jun 17, 2016

Correspondence

Jun 17, 2016

Correspondence

与美国证券交易委员会(SEC)的通信
Jun 17, 2016

Correspondence

与美国证券交易委员会(SEC)的通信
Aug 31, 2015

Correspondence

Jul 08, 2015

Correspondence

Apr 16, 2015

Correspondence

Apr 14, 2015

[Rev.]Annual Report

Mar 14, 2014

[Rev.]Annual Report

Jan 22, 2014

Major Issues Report

Apr 27, 2012

Correspondence

Feb 18, 2011

Correspondence

Jan 07, 2011

Correspondence

Dec 21, 2010

Major Issues Report

Dec 14, 2010

Correspondence

Jun 30, 2010

Employee Stock Ownership

More

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Apr 02, 2025 Post Market
Financial Report Announcement
Nov 07, 2024 Post Market
Financial Report Announcement
Aug 13, 2024 Post Market
Financial Report Announcement
Jul 11, 2024 Pre-Market
Split&Reverse Split
May 31, 2024 35 for 1

Dividend History

no data

No relevant data is available

Valuation Analysis

-0.45
Current
-1.73
Sector Average
61.36%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-0.45
Maximum
-0.06
+1 STD
-0.30
Minimum
-6.05
-1 STD
-3.17
Average
-1.73

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.